Agilent Technologies Appoints IMGM Laboratories Certified Service Provider for Gene Expression Microarrays
Agilent Technologies Inc. (NYSE: A) today announced that IMGM Laboratories GmbH has achieved Certified Service Provider status for the Agilent microarray platform.
IMGM achieved Agilent-certified status after completing training and passing a rigorous series of assessments that include: demonstrating proficiency in analyzing Agilent’s 60-mer oligo microarrays using the complete Agilent system; sample quality control using the Agilent 2100 Bioanalyzer; sample labeling using Agilent reagents and protocols; hybridization using SureHyb chambers; microarray analysis using the Agilent scanner and feature extraction software; and final data analysis using the GeneSpring bioinformatics platform.
“By switching to this powerful microarray platform, we’re able to further increase the value of our whole-genome gene expression service,” said Ralph Oehlmann, director of business development at IMGM. “In addition to offering our customers new applications, our service brings together high data quality, sound bioinformatics and clear, detailed reports.”
“I am very pleased to welcome IMGM as a Certified Service Provider,” said Chris Grimley, Agilent senior marketing director, Genomics. “They’ve demonstrated a quality approach to supporting customers’ research, and we look forward to a long and productive relationship.”
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.